MOLBIO
Active threads
Molbio Diagnostics Surges 21% on Market Debut
Molbio Diagnostics shares listed at a 21% premium over its IPO price, with the stock continuing to gain in early trading. The strong debut follows a positive response to the IPO, and the company is now trading well above its issue price. The listing is part of a broader trend of strong market debuts, with Dhoot Transmission also gaining 38%.
World Bank, HDFC AMC back Molbio Diagnostics IPO
IFC, the private-sector investment arm of the World Bank Group, last participated as an anchor investor in an Indian IPO in June 2021, when it invested Rs 10 crore in Dodla Dairy. According to news reports, IFC stayed invested in Dodla Dairy for three years until 2024. The investment marks a notable institutional endorsement for Molbio Diagnostics, which is regarded as Goa's first unicorn and is backed by Temasek and Motilal Oswal Private Equity.
Intelligence feed
No articles in the last 24 hours.